Hawkins, Inc. $HWKN Shares Purchased by Principal Financial Group Inc.

Principal Financial Group Inc. increased its stake in Hawkins, Inc. (NASDAQ:HWKN) by 12.7% in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 113,371 shares of the specialty chemicals company’s stock after acquiring an additional 12,767 shares during the quarter. Principal Financial Group Inc. owned approximately 0.54% of Hawkins worth $20,715,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in HWKN. AlphaQuest LLC increased its stake in shares of Hawkins by 15.4% during the third quarter. AlphaQuest LLC now owns 2,207 shares of the specialty chemicals company’s stock worth $403,000 after purchasing an additional 294 shares in the last quarter. New York State Common Retirement Fund lifted its stake in Hawkins by 137.5% in the 3rd quarter. New York State Common Retirement Fund now owns 16,302 shares of the specialty chemicals company’s stock valued at $2,979,000 after buying an additional 9,439 shares in the last quarter. TD Waterhouse Canada Inc. boosted its holdings in Hawkins by 492.0% in the 3rd quarter. TD Waterhouse Canada Inc. now owns 592 shares of the specialty chemicals company’s stock worth $106,000 after buying an additional 492 shares during the last quarter. Truist Financial Corp purchased a new stake in Hawkins during the 3rd quarter worth approximately $323,000. Finally, Parkside Financial Bank & Trust raised its holdings in shares of Hawkins by 694.1% during the third quarter. Parkside Financial Bank & Trust now owns 405 shares of the specialty chemicals company’s stock valued at $74,000 after acquiring an additional 354 shares during the last quarter. 69.71% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, Director James A. Faulconbridge purchased 1,500 shares of the business’s stock in a transaction dated Wednesday, February 4th. The stock was acquired at an average price of $129.29 per share, for a total transaction of $193,935.00. Following the acquisition, the director directly owned 50,907 shares of the company’s stock, valued at approximately $6,581,766.03. This represents a 3.04% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 4.10% of the stock is owned by corporate insiders.

More Hawkins News

Here are the key news stories impacting Hawkins this week:

• Positive Sentiment: Director James A. Faulconbridge increased his stake, purchasing 1,500 shares at an average $129.29 (total ~$193,935), bringing his holdings to ~50,907 shares (worth ~ $6.58M). Insider buying by a director is typically viewed as a confidence signal and likely helped lift the stock. Top Insider Just Made a Big Bet on This Under-the-Radar Company SEC Form 4
• Neutral Sentiment: Reported short interest shows 0 shares and a 0.0 days-to-cover ratio — this appears to be a reporting artifact or a very low short interest reading. Low/zero short interest reduces short-squeeze risk but offers limited directional insight. (Source: market data entry)
• Negative Sentiment: Sidoti (coverage) trimmed its FY2027 EPS estimate for Hawkins from $5.10 to $4.60 and published a cautious near-term view; the firm projects FY2028 at $5.10 and Q3 2028 at $1.01. Analyst downgrades can pressure the stock by lowering near-term expectations and investor sentiment. Sidoti Csr Has Pessimistic View of Hawkins FY2026 Earnings

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on HWKN. BWS Financial reaffirmed a “buy” rating and issued a $200.00 price target on shares of Hawkins in a research note on Thursday, January 29th. Weiss Ratings lowered Hawkins from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday, January 12th. Finally, Zacks Research raised shares of Hawkins from a “strong sell” rating to a “hold” rating in a report on Friday, January 2nd. Two research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, Hawkins presently has an average rating of “Hold” and a consensus price target of $162.50.

Hawkins Stock Performance

NASDAQ HWKN opened at $134.38 on Monday. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.46 and a current ratio of 2.35. The stock’s fifty day moving average is $144.54 and its two-hundred day moving average is $155.10. The firm has a market capitalization of $2.81 billion, a P/E ratio of 34.02, a price-to-earnings-growth ratio of 2.84 and a beta of 0.86. Hawkins, Inc. has a fifty-two week low of $98.30 and a fifty-two week high of $186.15.

Hawkins (NASDAQ:HWKN) last posted its quarterly earnings results on Wednesday, January 28th. The specialty chemicals company reported $0.72 EPS for the quarter, missing the consensus estimate of $0.75 by ($0.03). The company had revenue of $244.08 million for the quarter, compared to analysts’ expectations of $252.51 million. Hawkins had a return on equity of 16.85% and a net margin of 7.75%. On average, research analysts anticipate that Hawkins, Inc. will post 4 earnings per share for the current year.

Hawkins Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, February 27th. Stockholders of record on Friday, February 13th will be paid a $0.19 dividend. The ex-dividend date of this dividend is Friday, February 13th. This represents a $0.76 annualized dividend and a dividend yield of 0.6%. Hawkins’s dividend payout ratio is 19.24%.

Hawkins Company Profile

Hawkins, Inc (NASDAQ: HWKN) is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.

Hawkins’ product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.